我要投票 片仔癀药业在医疗保健行业中的票数:638
· 外 推 电 报 ·
2026-01-08 08:06:44 星期四

【片仔癀药业是哪个国家的品牌?】

片仔癀药业是什么牌子?「片仔癀药业」是 漳州片仔癀药业股份有限公司 旗下著名品牌。该品牌发源于福建,由创始人刘建顺在1555期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力片仔癀药业品牌出海!将品牌入驻外推网,定制片仔癀药业品牌推广信息,可以显著提高片仔癀药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

漳州片仔癀药业股份有限公司,是漳州市制药厂改制创立的,是全国“重合同、守信用”企业、国家火炬高新技术企业、福建省百家重点工业企业、居我国中成药行业50强。公司连续多年入选福建省工业主要行业竞争力十强、工业300强、工业效益300强、利税300强。公司以生产名贵中成药——片仔癀而享誉海内外,注册的“片仔癀”商标于1999年元月被评为“中国驰名商标”,2006年入选商务部首批“中华老字号”、并入选中华老字号品牌价值百强榜20强,福建省出口名牌,片仔癀系列产品首批通过国家原产地标记认证,并被评为福建省名牌产品。2002年经国家人事部批准,设立博士后科研工作站。公司股票于2003年6月16日在上海证券交易所成功上市,2003年度列全国1200多家上市公司综合绩效排名第11位,2004年被评为福建省大、中型国有及国有控股企业效绩“十佳”。

公司的主导产品——片仔癀,两度荣获国家质量金质奖,并被列入国家中药一级保护品种,其以独特的消炎、解毒、镇痛、保肝等显著疗效及保护健康的功能而深受国内外患者的赞誉,被誉为“国宝神药”,并大量出口东南亚、日本、韩国、加拿大等国家和地区,年出口创汇超千万美元,居中国中成药单项出口创汇首位。2000年片仔癀作为内地第一个获得香港政府创新及科技基金无偿资助的中成药研究项目,由香港中文大学进行片仔癀保肝作用研究。

公司视产品质量为企业的生命,严格按国家GMP规范要求组织生产。公司始终重视新药的研发和老产品二次开发工作。近年来,相继研制开发投产了包括金糖宁胶囊、心舒宝片、清热止咳颗粒、复方片仔癀含片、增乳膏等在内的十几个新产品,使公司每年都有新产品面市,老产品二次开发--片仔癀胶囊增加适应症的临床研究被国家列入“863”计划。

目前公司有如下几个系列产品:

1.片仔癀系列:片仔癀、片仔癀胶囊、复方片仔癀软膏、复方片仔癀痔疮软膏、复方片仔癀含片;

2.感冒止咳系列:清热止咳颗粒、川贝清肺糖浆、藿香正气水(胶囊)、金牡感冒片、小柴胡颗粒、板蓝根颗粒、小儿止咳糖浆等;

3.丸剂系列:六味地黄丸、杞菊地黄丸、知柏地黄丸、香砂六君丸、逍遥丸;

4.保肝护肝类:茵胆平肝胶囊、护肝片;

5.妇女儿童类:增乳膏、逍遥丸、小儿止咳糖浆;

6.心血管类:心舒宝片、复方丹参片;

7.其它:少林正骨精、牛黄解毒片、蜂乳胶囊、金糖宁胶囊等等;

8.另外还有仅供国外销售产品:龙江牌特效片仔癀暗疮膏、复方片仔癀肝宝、片仔癀活络油、片仔癀白花蛇解痒片、片仔癀润喉片、片仔癀消炎胶囊、片仔癀润喉糖、片仔癀跌打精等。

英文翻译:Zhangzhou Pianzihuang Pharmaceutical Co., Ltd. was founded by Zhangzhou pharmaceutical factory. It is a national "contract and credit" enterprise, a national torch high-tech enterprise, a hundred key industrial enterprises in Fujian Province, and one of the top 50 Chinese patent medicine enterprises in China. For many years, the company has been selected as one of the top ten industrial competitiveness, top 300 industry, top 300 industrial efficiency and top 300 profit and tax. The company is famous at home and abroad for the production of famous Chinese patent medicine - pianzehuang. The registered "pianzehuang" trademark was rated as "China's famous trademark" in January 1999. In 2006, it was selected as the first batch of "China's time-honored brand" by the Ministry of Commerce, and was listed as the top 20 in the top 100 brand value list of China's time-honored brand. Fujian Province's export famous brand, pianzehuang series of products passed the national origin mark certification in the first batch, and was evaluated It is a famous brand product in Fujian Province. In 2002, with the approval of the Ministry of personnel of the people's Republic of China, a postdoctoral research station was established. The company's shares were successfully listed on the Shanghai Stock Exchange on June 16, 2003. In 2003, it ranked 11th in the comprehensive performance of more than 1200 listed companies in China. In 2004, it was rated as the "top ten" performance of large, medium-sized state-owned and state-owned holding enterprises in Fujian Province. The company's leading product, pianzehuang, has twice won the national quality gold medal and has been listed in the first level national protection of traditional Chinese medicine. It is highly praised by patients at home and abroad for its unique anti-inflammatory, detoxification, analgesic, liver protection and other remarkable curative effects and health protection functions. It is known as the "national treasure drug" and exported to Southeast Asia, Japan, South Korea, Canada and other countries and regions, The annual export earnings exceed ten million US dollars, ranking first in the single export earnings of Chinese patent medicine. In 2000, as the first Chinese patent medicine research project funded by the Hong Kong government innovation and science and technology fund, the Chinese University of Hong Kong carried out the research on the liver protection effect of Pianzihuang. The company regards product quality as the life of the enterprise and organizes production in strict accordance with the requirements of GMP. The company always attaches great importance to the research and development of new drugs and the secondary development of old products. In recent years, more than ten new products including Jintangning capsule, Xinshubao tablet, Qingre Zhike granules, compound Pianzihuang buccal tablet, Zengyao and so on have been developed and put into production successively, which makes the company have new products on the market every year. The second development of old products -- clinical research on the indication of increasing Pianzihuang capsule has been listed in the "863" plan by the state. At present, the company has the following series of products: 1. Pianzihuang series: Pianzihuang, Pianzihuang capsule, compound Pianzihuang ointment, compound Pianzihuang hemorrhoids ointment, compound Pianzihuang buccal tablet; 2. Cold and cough series: Qingre Zhike granules, Chuanbei Qingfei syrup, Huoxiang Zhengqi water (capsule), Jinmu cold tablet, Xiaochaihu granules, Banlangen Granules, Xiaoer Zhike syrup, etc.; 3. Pills Series: Liuwei Dihuang pill, Qiju Dihuang pill, Zhibai Dihuang pill, Xiangsha Liujun pill, Xiaoyao Pill; 4. Liver protection and liver protection: yindanpinggan capsule, Hugan tablet; 5. Women and children: Zengyao, Xiaoyao Pill, Xiaoer cough syrup; 6. Cardiovascular: Xinshubao tablet, Fufang Danshen tablet; 7. Others: Shaolin zhenggujing, Niuhuang Jiedu tablet, bee milk capsule, Jintangning capsule, etc.; 8 In addition, there are only foreign products for sale: Longjiang brand special effect pianzehuang acne cream, compound pianzehuang Ganbao, pianzehuang Huoluo oil, pianzehuang Baihua snake antipruritic tablet, pianzehuang Runhou tablet, pianzehuang Xiaoyan capsule, pianzehuang Runhou sugar, pianzehuang drop hit essence, etc.

本文链接: https://www.waitui.com/brand/5a0277eda.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

具身机器人也有自己的保单,险企竞逐机器人保险业务

机器人租赁市场需求旺盛,也催生了大量的保险保障需求。多位业内人士认为,机器人保险作为新型保险产品,其发展成熟需要大量的数据支撑,如果仅与单一企业合作或投保单一设备,数据积累会比较慢。通过与租赁平台等合作,不仅可以获得批量保单,也有利于实现数据的快速积累,为精算定价、风险理赔提供数据支撑,机器人保险有望迎来新增长极。不过,机器人保险在我国还处在起步阶段,发展过程中的风险评估难、产品适配差、责任界定难、风控能力弱等问题,还需要多方协作、共同破局。(上证报)

7分钟前

日本11月份实际工资同比下降2.8%,为去年1月以来最大降幅

日本政府周四公布的初步数据显示,受一次性奖金大幅减少的拖累,日本11月份实际工资出现了自去年1月以来的最大降幅。与此同时,通胀超过工资增长的潜在趋势没有改变,这给日本央行带来了挑战。此前日本央行已发出信号,将在今年继续加息。(新浪财经)

7分钟前

机构称2026年铜市上行趋势明朗

2025年年末,国内铜现货(电解铜)价格突破100000元/吨关口,为铜市注入强劲动力。与此同时,2026年长单签订博弈进入白热化,国内提价潮、外贸溢价攀升、铜精矿加工费(TC/RC)低位僵持等现象集中出现。业内人士表示,这既反映出市场对供需格局的预判,也预示着2026年铜价或开启新一轮上涨行情。(中证网)

7分钟前

中信建投:商业航天产业有望进入新纪元

36氪获悉,中信建投指出,当前商业航天产业在国家政策支持和产业技术突破共同助力下,有望进入新纪元。商业航天产业涉及信息化的主要环节包括(1)遥感及其应用;(2)卫星测运控系统;(3)CAE仿真/卫星测试;(4)星际传输处理模块、通信模组、数据处理平台等;新场景扩展层面关注太空算力。此外,我们认为当前商业航天发展是国企与民营企业共振周期。

7分钟前

耐心资本布局硬科技,社保科创基金多地落子

长期资本正在重塑科技创新领域的投资生态。全国社会保障基金理事会官网显示,目前已成立的5只社保科创基金定位均为“服务国家发展的市场化基金”,旨在疏通金融资源进入实体经济的渠道,增加支持科技创新和产业创新深度融合的有效投资,在服务科技强国建设、助力科创企业成长中实现基金安全和保值增值。多位专家介绍,从浙江首发到江苏、福建、湖北、四川相继跟进,社保科创基金的迅速布局,标志着国家长期、耐心资本与区域创新战略的系统性对接已进入加速布局阶段。(上证报)

7分钟前

本页详细列出关于片仔癀药业的品牌信息,含品牌所属公司介绍,片仔癀药业所处行业的品牌地位及优势。
咨询